PHGDH and neoplasm: Finally, the authors employed an alternative means to decrease serine availability, by administering a phosphoglycerate dehydrogenase (PHGDH, first enzyme of the serine synthesis pathway) inhibitor that significantly reduced both plasma and tumour levels of serine and glycine concomitantly with toxic deoxysphingolipid accumulation.